Stay updated on Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page.

Latest updates to the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.4.3 has been added, replacing v3.4.2.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedAdded revision note v3.4.2 and removed revision note v3.4.1 from the page's revision history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check38 days agoChange DetectedRevision history updated to add v3.4.1 and remove v3.4.0.SummaryDifference0.0%

- Check52 days agoChange DetectedAdditions include Show glossary, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0. Deletions include Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page now displays Revision: v3.3.4 in place of Revision: v3.3.3.SummaryDifference0.0%

- Check88 days agoChange DetectedThe study locations list was updated to add multiple new sites across various countries/regions and to remove several existing sites. This changes the enrollment options and where data collection for the trial will occur.SummaryDifference2%

Stay in the know with updates to Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page.